Dosing and Dispensing Made Easy with Canine Epilepsy Treatment, EpiRepress
Friday, February 10, 2017
We have recently launched EpiRepress, a treatment for epilepsy in dogs which aims to make dosing and dispensing easy and accurate for practice staff and owners.
EpiRepress contains tried and trusted phenobarbital, the only ingredient licensed to treat both idiopathic and structural epilepsy, and which provides clinical improvement in 85% of cases.1 It is offered in the conventional 60mg tablet strength – but the tablet can then be split into two or into four to enable dosing to be tailored to the needs of an individual patient.
EpiRepress is the first epilepsy treatment to be offered in easy-to-dispense boxes of 30 tablets, removing the need for the practice team to handle and count out individual tablets from larger pots. The smaller box size also makes the purchase price more manageable for clients.
With the prevalence of canine epilepsy meaning that most practices are seeing at least one case a week, we offer an innovative range of resources to accompany EpiRepress to support practices and affected owners in its management.2 They contain the latest guidance on the diagnosis, treatment and management of Epilepsy and include a comprehensive Epilepsy Diary for owners, packed with useful questions and tips and a handy folder to keep the Diary and pet information together. We also have also created a diagnostic and treatment poster, including differential diagnoses, for use in practice.
Phenobarbital is the mainstay treatment for canine epilepsy and we wanted to offer practices and owners an easier, accurate and more cost-effective solution.1 EpiRepress, with its divisible 60mg tablets and smaller box size, is the result and we are delighted that it is now available.
- Podell, M., Volk, H. A., Berendt, M., Loscher, W., Munana, K., Patterson, E. E., & Platt, S. R. (2016). 2015 ACVIM Small Animal Consensus Statement on Seizure Management in Dogs, Journal of Veterinary Internal Medicine, 30, 477-490.
- IVETF (2015). International Veterinary Epilepsy Task Force Consensus Reports. Available at: www.biomedcentral.com/bmcvetres/series/IVETF_consensus_reports.
EpiRepress© 60 mg tablets for dogs. Tablets can be divided into halves and quarters and contain phenobarbital for oral use in dogs. Legal category: POM-V Schedule 3. Refer to the product packaging and leaflets for information about side effects, precautions, warnings and contra-indications. Advice should be sought from the medicine prescriber. Use medicines responsibly. www.noah.co.uk/responsible.